Embryonic hyperglycemia causes a reduction in photoreceptor cells and increased oxidative stress in the developing retina

Kayla Titialii,Ann Morris
DOI: https://doi.org/10.1096/fasebj.2020.34.s1.00336
2020-04-01
The FASEB Journal
Abstract:Poor blood glucose regulation has been linked to various long‐term metabolic disruptions in adults, such as tissue damage in the eye. Yet, little is known about the effects of embryonic hyperglycemia on retinal development. To address this question, our lab has established a protocol for inducing hyperglycemia in zebrafish embryos by submerging zebrafish embryos in fish water containing 50mM glucose +/− 10μM dexamethasone from 10 hours post fertilization (hpf) until 120 hpf. Following treatment, larval heads were either fixed for sectioning or used for RNA extraction and the remaining body was used to quantify glucose concentration. The fixed heads were processed for sectioning and immunohistochemistry to label and quantify cell types in the retina. Treatment with 50mM glucose + 10μM dexamethasone reliably produced hyperglycemic larvae, with at least 2.5‐fold increased whole‐body glucose concentration compared to control‐treated larvae. Our results show that hyperglycemic larvae had a significant reduction in rod and cone photoreceptors with abnormal morphology, and significant increase in reactive oxygen species (ROS) production in the retina. In addition, Müller glia cells showed abnormal morphology, but an increase in number. Finally, genes related to the pentose phosphate pathway were also up‐regulated in hyperglycemic eyes. Our results suggest that embryonic hyperglycemia results in abnormal photoreceptor development via ROS production, which is accompanied by an elevation in pentose phosphate pathway activity. As the population of women with uncontrolled diabetes during pregnancy continues to grow, it is imperative to pinpoint the effects of embryonic hyperglycemia. The similarities between humans and zebrafish will allow us to study these effects, which will aid in the development of therapeutic strategies. Gertrude F. Ribble Mini Grant, Department of Biology, University of Kentucky Diabetes Research Center, Washington University, Grant No. 5P30 DK020579
cell biology,biochemistry & molecular biology,biology
What problem does this paper attempt to address?